New insights in RA-ILD therapeutics

Save

RA associated ILD (RA-ILD) is the most common extra-articular manifestation in RA. Its prevalence varies considerably, ranging from 5% to 30%, and is often underestimated since patients only become symptomatic or display abnormalities on chest X-Ray at a late stage of disease, leading to subsequent delay in diagnosis. In this context, several groups advocate for an earlier and more precise detection, using high resolution chest computed tomography (HRCT), which is the most sensitive for pre-clinical RA-ILD diagnosis. But why would we want to diagnose early a manifestation that we cannot treat?

Turning the Corner on CV Risk in Rheumatoid Arthritis

Save

Cardiovascular (CV) disease remains the leading cause of mortality in rheumatoid arthritis (RA). A number of studies progressed our knowledge in the session Rheumatoid arthritis - comorbidity and clinical aspects – I on Thursday at EULAR 2021.

EULAR 2021 – Day 1 Report

Save

After the opening ceremonies and keynote speaker there were several enticing sessions and a plenary session full of great research and presentations.  Here are a few of the highlights that I saw.

EULAR 2021 - Day 1 Podcasts

Save

Check out this compilation of our EULAR 2021 Day 1 broadcasts below.

You can follow the EULAR 2021 RheumNow podcasts on iTunes and Soundclound.com

Listen by Clicking below:

Day 1a

EULAR 2021 - Opening Day

Save

RheumNow has begun covering EULAR 2021, the premier Rheumatology Congress that is usually held in Europe, but has gone virtual in 2021 because of the pandemic. We have several faculty members around the world reporting on the this year's meeting. Please visit RheumNow.com daily for the latest videos, tweet summaries, news articles and podcasts emanating from EULAR. Look for our coverage on these and other important topics:

Featured Abstracts from Industry at EULAR 2021

Save

Many great presentations this week at EULAR 2021 will feature industry sponsored clinical trials and reports.  Often these become the pivotal studies for regulatory approval and the annual congresses are their first look.

Foot Pain Commonly Overlooked in RA

Save

Foot pain is a common but underappreciated symptom of rheumatoid arthritis (RA) and can be associated with worse disease, European researchers found.

Best Interventions for Gout Flares

Save

A recent metanalysis assessed the comparative efficacy of current first-line pharmacologic antiinflammatory interventions for gout flares and surmised that canakinumab and intravenous or intramuscular corticosteroids are superior to  nonsteroidal antiinflammatory drugs [NSAIDs].

COLCORONA: Protective Effect of Colchicine in COVID-19

Save

Lancet Respiratory Medicine has reported the results of the COLCORONA trial, showing that in patients with PCR-confirmed COVID-19 infection, colchicine led to a significantly lower rate of death or hospital admission from COVID.

RheumNow Podcast – Heart, Lung & Liver (5.28.2021)

Save

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com.

Methotrexate Impairs COVID Vax Response

Save

One-third of patients with immune-mediated inflammatory diseases being treated with methotrexate showed attenuated responses to the COVID-19 vaccine, researchers reported.

Efficacy of 6 Weeks Antibiotics with Prosthetic Joint Infections

Save

The NEJM has published the results of a French multicenter study showing that prosthetic joint infections can be successfully managed with 6 weeks of antibiotic therapy; this was noninferior and had better outcomes compared to 12 weeks of antibiotic therapy.